چالش های باروری و ملاحظات مرتبط با فناوری کمک باروری در زوجین مبتلا به هپاتیت B: (مقاله مروری)

نوع مقاله : مروری

نویسندگان

1 مربی گروه مامایی، دانشکده پرستاری و مامایی، دانشگاه آزاد اسلامی واحد تبریز، تبریز، ایران.

2 دانشجوی دکترای تخصصی بهداشت باروری، کمیته تحقیقات دانشجویی، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی شهید بهشتی تهران، تهران، ایران.

3 استاد گروه غدد تولید مثل و جنین شناسی، مرکز تحقیقات باروری ناباروری، دانشکده پزشکی، دانشگاه علوم پزشکی شهید بهشتی تهران، تهران، ایران.

چکیده

مقدمه: ویروس هپاتیت B شایع‌ترین ویروس تهدید کننده سلامت انسان و یک بیماری منتقله از راه جنسی و خونی است. مطالعات بیانگر اثرات منفی عفونت های ویروسی بر باروری انسان بوده و در حال حاضر استفاده از تکنیک‌های کمک باروری در افراد مبتلا به عفونت های منتقله جنسی در حال افزایش است. مطالعه حاضر با هدف بررسی چالش‌های باروری و پیامد فناوری کمک باروری زوجین مبتلا به عفونت هپاتیت B و چگونگی انتقال عفونت از سلول‌های جنسی انجام شد.
روش کار: مطالعه حاضر یک مطالعه مروری است که داده‌های آن از مقالات بانک‌های اطلاعاتیGoogle scholar ، Medline (PubMed)، Cochran و Science direct جمع‌آوری شد. جستجوی جامع با استفاده از کلیدواژه‌های  Hepatitis Bو (infertility، male infertility، Female infertility، ART،Father to fetal transmission) انجام شد. با استفاده از قابلیت جستجوی پیشرفته، تمام مقالات چاپ شده طی 5 سال اخیر (2015-2010) که به زبان انگلیسی و دارای متن کامل بودند، انتخاب و پس از بررسی اولیه و جستجو بر اساس فهرست منابع، 43 مقاله وارد مطالعه شدند.
یافته ها: در مطالعه حاضر به جنبه‌های مختلفی از مسائل مرتبط با زوجین نابارور و بارور مبتلا به هپاتیت B که خواهان استفاده از فناوری کمک باروری هستند، پرداخته شد. نتایج بدست آمده نشان داد که اولاً غربالگری در زوجین مبتلا و افراد اهداءکننده سلول های جنسی، برای انجام اقدامات لازم و مشاوره مناسب بایستی الزامی شود ثانیاً ویروس هپاتیت در سلول‌های جنسی مخصوصاً به صورت آزاد و ادغام یافته با DNA می‌تواند اثرات منفی بر باروری و پیامد روش‌های کمک باروری داشته و می تواند از طریق سلول‌های جنسی به جنین انتقال یابد و در نهایت این که از شستشوی اسپرم و فناوری کمک باروری، می‌توان برای پیشگیری از انتقال ویروس استفاده نمود.
نتیجه گیری: یافته‌های پژوهش بیانگر اهمیت انجام غربالگری و استفاده از فناوری کمک باروری برای کاهش خطر انتقال عفونت هپاتیت B می‌باشد.

کلیدواژه‌ها

عنوان مقاله [English]

Fertility Challenges and Considerations Related to Assisted Reproductive Technology in Couples with Hepatitis B: (Review Article)

نویسندگان [English]

  • Azita Fathnezhad kazemi 1
  • Nasibeh Sharifi 2
  • Maarefat Ghafari Novin 3
1 Instructor, Department of Midwifery, Tabriz Branch, Islamic Azad University, Tabriz, Iran
2 PhD Student of Reproductive Health, Student Research Committee, School of Nursing and Midwifery, Tehran Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Professor, Department of Reproductive Endocrinology and Embryology, Infertility and Fertility Research Centre, Tehran Shahid Beheshti University of Medical Sciences, Tehran, Iran
چکیده [English]

Introduction: Hepatitis B is the most common viral human health threat and is spread through sex and blood. Research has revealed negative effects of viral infections on human fertility while currently using assisted reproductive technology is increasing in persons affected by sexually transmitted diseases. The aim of the present study was a survey on fertility challenges, outcomes of assisted reproductive technology in couples affected by hepatitis B, and how the infection is transmitted through gametes.
Methods: Data for the present review article were collected from Google Scholar, Medline (Pubmed), Cochran, and ScienceDirect databases. Using hepatitis B and (infertility, male infertility, female infertility, ART, father to fetal transmission) keywords and advanced search, all full-text English articles published in the last five years (2010–2015) were chosen. After preliminary inspection and resource appendix search, 43 articles were selected.
Results: This article describes various aspects of problems associated with fertile and infertile couples with hepatitis B who are willing to use assisted reproductive technology. Results showed that firstly, screening the affected couples and gamete donors for taking the necessary actions and appropriate consultation must be mandatory, and secondly, the hepatitis virus in gametes in free form or integrated with the DNA can have negative effects on fertility and the outcome of assisted reproductive techniques, and can be transmitted via gametes to fetuses and finally, sperm washing and assisted reproductive technology can be used for prevention of virus transmission.
Conclusion: Research findings demonstrate the importance of screening and the use of assisted reproductive technology to reduce the risk of hepatitis B infection.

کلیدواژه‌ها [English]

  • Assisted reproductive technology
  • Gametes
  • Hepatitis B
  • Infertility

مراجع

  1. Bu Z, Kong H, Li J, Wang F, Guo Y, Su Y, et al. Effect of male hepatitis B virus infection on outcomes of in vitro fertilization and embryo transfer treatment: insights from couples undergoing oocyte donation. Int J Clin Exp Med 2014; 7(7):1860-6.
  2. Technical content reviewed by the Centers for Disease Control and Prevention. Every week hundreds of people get hepatitis B. Available at: URL: www.immunize.org/catg.d/p4112.pdf; 2012.
  3. Zhou XL, Sun PN, Huang TH, Xie QD, Kang XJ, Liu L. Effects of hepatitis B virus S protein on human sperm function. Hum Reprod 2009; 24(7):1575–83.
  4. Hu XL, Zhou XP, Qian YL, Wu GY, Ye YH, ZhuYM. The presence and expression of the hepatitis B virus in human oocytes and embryos. Hum Reprod 2011; 26(7):1860-7.
  5. Huang J, Zhong Y, Fang X, Xie Q, Kang X, Wu R, et al. Hepatitis B virus S protein enhances sperm apoptosis and reduces sperm fertilizing capacity in vitro. PLoS One 2013; 8(7):1-4.
  6. Oger P, Yazbeck C, Gervais A, Dorphin B, Gout C, Jacquesson L, et al. Adverse effects of hepatitis B virus on sperm motility and fertilization ability during IVF. Reprod Biomed Online 2011; 23(2):207–12.
  7. Shi L, Liu S, Zhao W, Zhou H, Ren W, Shi J. Hepatitis B virus infection reduces fertilization ability during in vitro fertilization and embryo Transfer. J Med Virol 2014; 86(7):1099–104.
  8. Lin S, Li R, Zheng X, Wang L, Ren X, Chen L, et al. Impact of hepatitis B virus carrier serostatus on neonatal outcomes after IVF-ET. Int J Clin Exp Med 2015; 8(4):6206-11.
  9. Lam P, Suen SH, Lao TT, Cheung LP, Leung TY, Haines C. Hepatitis B infection and outcomes of in vitro fertilization and embryo transfer treatment. Fertil Steril 2010; 93(2):480-5.
  10. Abdi F, Ghaffari Novin M, Afrakhteh M, Khorvash F, Beheshti S. Hepatitis B and pregnancy: an update review article. World J Obstet Gynecol 2015; 4(1):1-8.
  11. Lee VC, Ng EH, Yeung WS, Ho PC. Impact of positive hepatitis B surface antigen on the outcome of IVF treatment. Reprod Biomed Online 2010; 21(5):712–7.
  12. Roshan N, Nasrin S, Farzam F. Prevalence of HBsAg, HCV and HIV antibodies among infertile couples in Ahvaz, south-west Iran. Jundishapur J Microbiol 2012; 5(2):393-7.
  13. Zhou XP, Hu XL, Zhu YM, Qu F, Sun SJ, Qian Y. Comparison of semen quality and outcome of assisted reproductive techniques in Chinese men with and without hepatitis B. Asian J Androl 2011; 13(3):465–9.
  14. Franco E, Bagnato B, Marino MG, Meleleo C, Serino L, Zaratti L. Hepatitis B: epidemiology and prevention in developing countries. World J Hepatol 2012; 4(3):74-80.
  15. Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int 2009; 29(Suppl 1):133–9.
  16. Han GR, Xu CL, Zhao W,Yang YF. Management of chronic hepatitis B in pregnancy. World J Gastroenterol 2012; 18(33):4517-21.
  17. Kumar A. Hepatitis B virus infection and pregnancy: a practical approach. Indian J Gastroenterol 2012; 31(2):43–54.
  18. Garolla A, Pizzol D, Bertolodo A, Menegazzo M, Barzon L, Foresta C. Sperm viral infection and male infertility: focus on HBV, HCV, HIV, HPV, HSV, HCMV, and AAV. J Reprod Immunol 2013; 100(1):20-9.
  19. Molina I, Carmen Del Gonzalvo M, Clavero A, Angel López-Ruz M, Mozas J, Pasquau J, et al. Assisted reproductive technology and obstetric outcome in couples when the male partner has a chronic viral disease. Int J Fertil Steril 2014; 7(4):291-300.
  20. Savasi V, Ferrazzi E, Fiore S. Reproductive assistance for infected couples with bloodborne viruses. Placenta 2008; 29(Supple B):160–5.
  21. Gilling-Smith C, Emiliani S, Almeida P, Liesnard C, Englert Y. Laboratory safety during assisted reproduction in patients with blood-borne viruses. Hum Reprod 2005; 20(6):1433–8.
  22. 22- Kalu E, Wood R, Vourliotis M, Gilling-Smith C. Fertility needs and funding in couples with blood-borne viral infection. HIV Med 2010; 11(1):90–3.
  23. Ajayi AB, Oladokun A, Bello FB, Morhason‑Bello IO, Ogundepo MO. Viral infections among couples for assisted reproduction in a fertility clinic in Nigeria. Niger J Clin Pract 2013; 16(3):352-5.
  24. Mansoor AA, Salih AI, Al-Jaroudi DH. Screening of hepatitis B and C and human immunodeficiency virus in infertile couples in Saudi Arabia. Saudi Med J 2011; 32(3):260-4.
  25. Osemwenkha AP, Ibadin KO, Enabulele OI, Ibeh IN. Sero prevalence of hepatitis B virus among infertile women recruited for Assisted Reproduction Technology (ART). Malaysian J Microbiol 2011; 7(4):230-2.
  26. Wingfield M, Cottell E. Viral screening of couples undergoing partner donation in assisted reproduction with regard to EU Directives 2004/23/EC, 2006/17/EC and 2006/86/EC: what is the evidence for repeated screening? Hum Reprod 2010; 25(12):3058–65.
  27. Walsh AP, Omar AB, Marron KD, Walsh DJ, Salma U, Sills ES. Recipient screening in IVF: first data from women undergoing anonymous oocyte donation in Dublin. Reprod Health 2011; 8:8-12.
  28. Hughes C, Grundy K, Emerson G, Mocanu E. Viral screening at the time of each donation in ART patients: is it justified? Hum Reprod 2011; 26(11):3169-72.
  29. Lutgens S, Nelissen EC, van Loo IH, Koek GH, Derhaag JG, Dunselman GA. To do or not to do: IVF and ICSI in chronic hepatitis B virus carriers. Hum Reprod 2009; 24(11):2676–8.
  30. Brookings C, Goldmeier D, Sadeghi-Nejad H. Sexually transmitted infections and sexual function in relation to male fertility. Korean J Urol 2013; 54(3):149-56.
  31. Rusz A, Pilatz A, Wagenlehner F, Linn T, Diemer T, Schuppe HC, et al. Influence of urogenital infections and inflammation on semen quality and male fertility. World J Urol 2012; 30(1):23-30.
  32. Bezold G, Politch JA, Kiviat NB, Kuypers JM, Wolff H, Anderson DJ. Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. Fertil Steril 2007; 87(5):1087-97.
  33. Kang X, Xie Q, Zhou X, Li F, Huang J, Liu D, et al. Effects of hepatitis B virus S protein exposure on sperm membrane integrity and functions. PloS One 2012; 7(3):e3341.
  34. Pirwany IR, Phillips S, Kelly S, Buckett W, Tan SL. Reproductive performance of couples discordant for hepatitis b and c following IVF treatment. J Assist Reprod Genet 2004; 21(5):157-61.
  35. Chen JM, Cui Y, Zhang XX. Investigate the impact of hepatitis B virus infection on sperm DNA integrity. Chin J Exp Clin Virol 2011; 25(5):345-7.
  36. Cao LH, Liu ZM, Zhao PL, Sun SC, Xu DB, Shao MH, et al. Efficacy of combined hepatitis B immunoglobulin and hepatitis B vaccine in blocking father-infant transmission of hepatitis B viral infection. Genet Mol Res 2015; 14(2):4651-7.
  37. van Leeuwen E, Wit FW, Repping S, Eeftinck Schattenkerk JK, Reiss P, van der Veen F, et al. Effects of antiretroviral therapy on semen quality. AIDS 2008; 22(5):637–42.
  38. Lorusso F, Palmisano M, Chironna M, Vacca M, Masciandaro P, Bassi E, et al. Impact of chronic viral diseases on semen parameters. Andrologia 2010; 42(2):121-6.
  39. Su S, Chang SN, Sung FC, Su CT, Shieh YH, Lin CC, et al. Hepatitis B virus infection and the risk of male infertility: a population-based analysis. Fertil Steril 2014; 102(6):1677–84.
  40. Huang J, Huang TH, Qiu HY, Fang XW, Zhuang TG, Liu HX, et al. Effects of hepatitis B virus infection on human spermchromosomes. World J Gastroenterol 2003; 9(4):736-40.
  41. Chen H, Ge HS, Lv JQ, Wu XM, Xi HT, Huang JY, et al. Chronic hepatitis B virus infection in women is not associatedwith IVF/ICSI outcomes. Arch Gynecol Obstet 2014; 289(1):213-7.
  42. Zhang L, Zhang W, Shao C, Zhang J, Men K, Shao Z, et al. Establishment and characterization of a spontaneously immortalized trophoblast cell line (HPT-8) and its hepatitis B virus-expressing clone. Hum Reprod 2011; 26(8):2146–56.
  43. 43- Lou H, Ding W, Dong M, Zhu Y, Zhou C, Wang Z, et al. The presence of hepatitis B surface antigen in the ova of pregnant women and its relationship with intra-uterine infection by hepatitis B virus. J Int Med Res 2010; 38(1):214–9.
  44. Steyaert SR, Leroux-Roels GG, Dhont M. Infection in IVF: review and guidelines. Hum Reprod Update 2000; 6(5):432-41.
  45. Cai Q, Zhu Y. Is hepatitis B virus transmitted via the male germ line? A seroepidemiological study in fetuses. Int J Infect Dis 2013; 17(1):e54–8.
  46. Fei QJ, Yang XD, Ni WH, Pan CS, Huang XF. Can hepatitis B virus DNA in semen be predicted by serum levels of hepatitis B virus DNA, HBeAg, and HBsAg in chronically infected men from infertile couples? Andrology 2015; 3(3):506–11.
  47. Cao L, Li YR, Wang SY, Liu ZM, Sun SC, Xu DB, et al. Effect of hepatitis B vaccination in hepatitis B surface antibody‑negative pregnant mothers on the vertical transmission of hepatitis B virus from father to infant. Exp Ther Med 2015; 10(1):279-84.
  48. Zhao EY, Chen SL, Sun L, Yin MN, Xiong XS, Song J, et al. Influence of chronic HBV infection in the husband on the outcome of IVF-ET treatment. Nan Fang Yi Ke Da Xue Xue Bao 2007; 27(12):1827-9.

مجله زنان، مامایی و نازایی ایران
دوره 18، شماره 182
هفته چهارم بهمن ماه 1394
بهمن 1394
صفحه 18-30

فایل ها

هم رسانی

ارجاع به این مقاله

آمار